FDA Could Reportedly Sign Off On Pfizer Covid Booster Shots For All Adults This Week

United States News News

FDA Could Reportedly Sign Off On Pfizer Covid Booster Shots For All Adults This Week
United States Latest News,United States Headlines
  • 📰 Forbes
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 53%

Millions of additional Americans could become eligible for an extra dose of Pfizer’s coronavirus vaccine as early as Thursday, the New York Times and NBC report.

If the FDA signs off on expanded booster shots, the Centers for Disease Control and Prevention is expected to weigh the issue next. Anauthorized boosters

for all three Covid-19 vaccines, but eligibility varies. Anybody who took Johnson & Johnson’s single-shot vaccine can get an extra dose, but boosters for Pfizer and Moderna’s vaccines are only authorized for elderly people or adults who face an amplified Covid-19 risk due to their job or an underlying health issue. In September, the FDA’s advisory panel chose not toPfizer booster shots for everybody 16 and older, arguing the vaccine is still highly effective against severe illness and death.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Forbes /  🏆 394. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA expected to authorize Pfizer booster for all adults this weekFDA expected to authorize Pfizer booster for all adults this weekThe FDA is expected to authorize Pfizer's Covid booster for all adults this week. A CDC advisory committee, ACIP, will meet on Friday to discuss boosters.
Read more »

FDA Will Authorize Pfizer COVID Booster Shot for All Adults: ReportFDA Will Authorize Pfizer COVID Booster Shot for All Adults: ReportThe move is expected within days, after several states and New York City made the extra shots available over the past week.
Read more »

FDA expected to authorize Pfizer COVID-19 booster for all adults this weekFDA expected to authorize Pfizer COVID-19 booster for all adults this weekThe move could come as early as Thursday.
Read more »

Pfizer seeks FDA emergency use authorization for its experimental Covid-19 antiviral pillPfizer seeks FDA emergency use authorization for its experimental Covid-19 antiviral pillPfizer announced Tuesday that it is seeking emergency use authorization from the US Food and Drug Administration for its experimental antiviral Covid-19 pill, known as PF-07321332 or Paxlovid.
Read more »

Pfizer Seeks FDA Emergency Use Authorization for Its COVID-19 PillPfizer Seeks FDA Emergency Use Authorization for Its COVID-19 PillPfizer has signed a deal to allow other manufacturers to make its experimental COVID-19 pill, possibly opening up access to treatment to countries across the world:
Read more »



Render Time: 2025-02-22 22:21:49